RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+31.11%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$3.42B
AUM Growth
+$3.42B
(+37%)
Cap. Flow
+$357M
Cap. Flow
% of AUM
10.46%
Top 10 Holdings %
Top 10 Hldgs %
45.63%
Holding
88
New
10
Increased
35
Reduced
24
Closed
6
Top Buys
| 1 |
Amicus Therapeutics
FOLD
|
$154M |
| 2 |
CELG
Celgene Corp
CELG
|
$50.5M |
| 3 |
Align Technology
ALGN
|
$40.7M |
| 4 |
Biogen
BIIB
|
$39.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
$35.5M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$134M |
| 2 |
Cigna
CI
|
$44.1M |
| 3 |
Medtronic
MDT
|
$38.2M |
| 4 |
CVS Health
CVS
|
$25.1M |
| 5 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
$20.7M |
Sector Composition
| 1 | Healthcare | 94.57% |
| 2 | Financials | 2.23% |
| 3 | Energy | 0.01% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
26
DELISTED
Cymabay Therapeutics
CBAY
| $39.1M | 1.14% | 2,943,765 -5,100 | -0.2% | -$67.7K |
|
|
27
Biogen
BIIB
$19.4B
| $39.1M | 1.14% | +165,300 | New | +$39.1M |
|
28
Scholar Rock
SRRK
$3.14B
| $38.5M | 1.13% | 2,051,089 +289,682 | +16% | +$5.44M |
|
29
Jazz Pharmaceuticals
JAZZ
$7.75B
| $38.5M | 1.13% | 269,480 +132,800 | +97% | +$19M |
|
|
DCPH
30
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $37.8M | 1.11% | 1,628,653 -24,527 | -1% | -$569K |
|
31
AnaptysBio
ANAB
$569M
| $36.3M | 1.06% | 496,918 +132,868 | +36% | +$9.71M |
|
|
IMGN
32
DELISTED
Immunogen Inc
IMGN
| $35.4M | 1.04% | 13,063,767 +2,179,160 | +20% | +$5.91M |
|
|
OXFD
33
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $34.5M | 1.01% | 2,001,467 -226,040 | -10% | -$3.89M |
|
34
Replimune Group
REPL
$422M
| $33.7M | 0.99% | 2,212,456 +23,499 | +1% | +$358K |
|
35
UnitedHealth
UNH
$281B
| $32.9M | 0.96% | 132,890 +17,390 | +15% | +$4.3M |
|
|
NVTA
36
DELISTED
Invitae Corporation
NVTA
| $32.2M | 0.94% | 1,374,175 +848,800 | +162% | +$19.9M |
|
|
GRTS
37
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $31.3M | 0.92% | 2,353,735 +84,599 | +4% | +$1.13M |
|
38
Xeris Biopharma Holdings
XERS
$1.26B
| $30.1M | 0.88% | 3,000,641 +588,000 | +24% | +$5.9M |
|
|
TCRR
39
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $28.7M | 0.84% | +1,807,256 | New | +$28.7M |
|
|
CBIO
40
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $25.1M | 0.74% | 2,018,247 +39,700 | +2% | +$495K |
|
41
Teladoc Health
TDOC
$1.37B
| $24.5M | 0.72% | 439,900 +244,300 | +125% | +$13.6M |
|
|
MOR
42
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $20.3M | 0.59% | 893,800 -1,800 | -0.2% | -$40.9K |
|
|
EIDX
43
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $20M | 0.58% | 851,900 -1,600 | -0.2% | -$37.5K |
|
|
HSKA
44
DELISTED
Heska Corp
HSKA
| $19.2M | 0.56% | 226,013 +28,300 | +14% | +$2.41M |
|
|
PRAH
45
DELISTED
PRA Health Sciences, Inc.
PRAH
| $19.2M | 0.56% | 174,000 -20,800 | -11% | -$2.29M |
|
|
TCDA
46
DELISTED
Tricida, Inc. Common Stock
TCDA
| $18.9M | 0.55% | 490,300 -2,300 | -0.5% | -$88.8K |
|
|
VAPO
47
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $18.9M | 0.55% | 1,011,316 -235,709 | -19% | -$4.41M |
|
|
SYRS
48
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $15M | 0.44% | 1,645,200 -4,338 | -0.3% | -$39.6K |
|
|
AXNX
49
DELISTED
Axonics, Inc. Common Stock
AXNX
| $14.3M | 0.42% | 598,600 -1,400 | -0.2% | -$33.5K |
|
50
ICU Medical
ICUI
$3.15B
| $12.4M | 0.36% | 51,721 -39,600 | -43% | -$9.48M |
|